| Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo R Aslam, ER Speck, M Kim, AR Crow, KWA Bang, FP Nestel, H Ni, ... Blood 107 (2), 637-641, 2006 | 617 | 2006 |
| Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells V Siragam, AR Crow, D Brinc, S Song, J Freedman, AH Lazarus Nature medicine 12 (6), 688-692, 2006 | 317 | 2006 |
| Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk A Podolanczuk, AH Lazarus, AR Crow, E Grossbard, JB Bussel Blood, The Journal of the American Society of Hematology 113 (14), 3154-3160, 2009 | 316 | 2009 |
| IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity AR Crow, S Song, J Freedman, CD Helgason, RK Humphries, ... Blood 102 (2), 558-560, 2003 | 158 | 2003 |
| IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity AR Crow, S Song, JW Semple, J Freedman, AH Lazarus British journal of haematology 115 (3), 679-686, 2001 | 152 | 2001 |
| Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of … D Zipris, AH Lazarus, AR Crow, M Hadzija, TL Delovitch Journal of immunology (Baltimore, Md.: 1950) 146 (11), 3763-3771, 1991 | 134 | 1991 |
| Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? V Siragam, D Brinc, AR Crow, S Song, J Freedman, AH Lazarus The Journal of clinical investigation 115 (1), 155-160, 2005 | 133 | 2005 |
| The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? AR Crow, AH Lazarus Transfusion medicine reviews 22 (2), 103-116, 2008 | 124 | 2008 |
| Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG S Song, AR Crow, J Freedman, AH Lazarus Blood, The Journal of the American Society of Hematology 101 (9), 3708-3713, 2003 | 103 | 2003 |
| Mechanism of action of IVIG and anti-D in ITP AH Lazarus, AR Crow Transfusion and Apheresis Science 28 (3), 249-255, 2003 | 100 | 2003 |
| A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? AR Crow, S Song, JW Semple, J Freedman, AH Lazarus Blood 109 (1), 155-158, 2007 | 99 | 2007 |
| Role of Fcγ receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura AR Crow, AH Lazarus Journal of pediatric hematology/oncology 25, S14-S18, 2003 | 93 | 2003 |
| Monoclonal antiprothrombinase (3D4. 3) prevents mortality from murine hepatitis virus (MHV-3) infection. C Li, LS Fung, S Chung, A Crow, N Myers-Mason, MJ Phillips, ... The Journal of experimental medicine 176 (3), 689-697, 1992 | 90 | 1992 |
| Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg S Song, AR Crow, V Siragam, J Freedman, AH Lazarus Blood 105 (4), 1546-1548, 2005 | 72 | 2005 |
| Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia AR Crow, S Song, V Siragam, AH Lazarus Pediatric blood & cancer 47 (S5), 710-713, 2006 | 66 | 2006 |
| Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection LS Fung, G Neil, J Leibowitz, EH Cole, S Chung, A Crow, GA Levy Journal of Biological Chemistry 266 (3), 1789-1795, 1991 | 66 | 1991 |
| New insight into the mechanism of action of IVIg: the role of dendritic cells AR Crow, D Brinc, AH Lazarus Journal of thrombosis and haemostasis 7, 245-248, 2009 | 65 | 2009 |
| Comparison of platelet immunity in patients with SLE and with ITP AH Lazarus, J Ellis, JW Semple, M Mody, AR Crow, J Freedman Transfusion Science 22 (1-2), 19-27, 2000 | 65 | 2000 |
| The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia AR Crow, SJ Suppa, X Chen, PJ Mott, AH Lazarus Blood, The Journal of the American Society of Hematology 118 (24), 6403-6406, 2011 | 51 | 2011 |
| Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice D Zipris, AR Crow, TL Delovitch Diabetes 40 (4), 429-435, 1991 | 49 | 1991 |